Search for dissertations about: "b-subunit"
Showing result 1 - 5 of 31 swedish dissertations containing the word b-subunit.
-
1. Cholera toxin B subunit as a carrier for inducing mucosal immunity and/or peripheral tolerance
Abstract : When an antigen is introduced via a mucosal route, either immunity or tolerance, or even both may be induced. Both immunity and tolerance are actively induced phenomena and both of them could have important medical implications as well as potential prophylactic or therapeutic applications. READ MORE
-
2. Genetic modification of cholera toxin B subunit for mucosal anti-infectious or anti-pathologic vaccination
Abstract : The development of mucosal vaccines requires antigen delivery systems that can efficiently help to present vaccine antigens to the mucosal immune system. En efficient and well known antigen carrier/delivery system is the B subunit of cholera toxin (CTB). READ MORE
-
3. Antigen presentation by dendritic cells and immunomodulation by cholera toxin B subunit. Implications for vaccine development
Abstract : Antigen presentation by dendritic cells is the first event that takes place upon initiation of an acquired immune response. The inductive events during antigen presentation will essentially govern the orientation and the magnitude of the subsequent immune responses. READ MORE
-
4. PROTEIN VACCINE AGAINST NEONATAL GROUP B STREPTOCOCCAL INFECTION Immunization experiments in animals and a serological study in humans
Abstract : Infection with group B streptococcus (GBS), an encapsulated bacterium, is an important cause of neonatal morbidity and mortality. Capsular polysaccharides and cell surface proteins of GBS are candidate antigens for development of a human GBS vaccine. Proteins have many advantages as vaccine antigens. READ MORE
-
5. Group B streptococcus capsular polysaccharide - Cholera toxin B subunit conjugate vaccine for mucosal immunisation : development and preclinical evaluation of experimental conjugate vaccines
Abstract : Group B streptococci (GBS) can colonize the female genital and rectal tracts and cause invasive infection in susceptible newborns. An optimally effective GBS vaccine should induce both mucosal and systemic immunity. READ MORE